We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Can Broccoli Cure Cancer?

By Biotechdaily staff writers
Posted on 15 Jan 2004
A natural compound derived from certain vegetables such as broccoli has shown the ability to prevent cancer and may ultimately cure some cancers, according to researchers at the Texas Agricultural Experiment Station of Texas A&M University (College Station, USA; www.tamu.edu). More...


Earlier research showed that chemically altered diindolylmethane (DIM) from broccoli could inhibit the growth of breast cancer cells in laboratory studies. Subsequent research showed similar compounds also inhibited the growth of pancreatic, colon, bladder, and ovarian cancer cells in culture. The Texas A&M investigators wondered if similar compounds could be developed for the treatment of cancer that had already developed. They explored how the compounds block cancer growth and found that they target PPAR gamma, a protein highly active in fat cells and overexpressed in many tumors and thus a potential target for new drugs

The researchers chemically modified "natural” DIM by adding a series of compounds that target the PPAR gamma and stop the growth of cancer. "One of the best parts is that this treatment appears to have minimal or no side effects in the mice trials. It just stops tumor growth,” said Dr. Steve Safe, a chemist at the Experiment Station who has been studying cancer for about 10 years.

Dr. Safe's patent has been acquired by Plantacor, a new biotech company headquartered in College Station (TX, USA), and the compound is expected to enter clinical trials soon in collaboration with M.D. Anderson Cancer Center in Houston (TX, USA).




Related Links:
Texas A&M

Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Real-Time PCR System
Gentier 96T
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.